Streptococcus Pneumoniae

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi

Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months

Immunogenicity of a Reduced Primary Schedule for Pneumococcal Conjugate Vaccine in UK Infants

Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults

PCV10 Immunogenicity Study Nepal 2015

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

PICR-b Nasopharyngeal S. Pneumoniae and Nasal S. Aureus Carriage Study

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine